PL1725526T3 - Sposób wytwarzania oksymów pirolidyny - Google Patents

Sposób wytwarzania oksymów pirolidyny

Info

Publication number
PL1725526T3
PL1725526T3 PL05708062T PL05708062T PL1725526T3 PL 1725526 T3 PL1725526 T3 PL 1725526T3 PL 05708062 T PL05708062 T PL 05708062T PL 05708062 T PL05708062 T PL 05708062T PL 1725526 T3 PL1725526 T3 PL 1725526T3
Authority
PL
Poland
Prior art keywords
preparing pyrrolidine
oximes
pyrrolidine oximes
preparing
formula
Prior art date
Application number
PL05708062T
Other languages
English (en)
Inventor
William Nadler
Doris Pupowicz
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of PL1725526T3 publication Critical patent/PL1725526T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL05708062T 2004-02-26 2005-02-28 Sposób wytwarzania oksymów pirolidyny PL1725526T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04100773 2004-02-26
PCT/EP2005/050852 WO2005082848A2 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes
EP05708062A EP1725526B1 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes

Publications (1)

Publication Number Publication Date
PL1725526T3 true PL1725526T3 (pl) 2008-03-31

Family

ID=34896105

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05708062T PL1725526T3 (pl) 2004-02-26 2005-02-28 Sposób wytwarzania oksymów pirolidyny

Country Status (21)

Country Link
US (1) US20070197794A1 (pl)
EP (1) EP1725526B1 (pl)
JP (1) JP2007524702A (pl)
KR (1) KR20060124775A (pl)
CN (1) CN1946686A (pl)
AT (1) ATE380792T1 (pl)
AU (1) AU2005217153A1 (pl)
BR (1) BRPI0508059A (pl)
CA (1) CA2554767A1 (pl)
CY (1) CY1107139T1 (pl)
DE (1) DE602005003803T2 (pl)
DK (1) DK1725526T3 (pl)
EA (1) EA011026B1 (pl)
ES (1) ES2296137T3 (pl)
IL (1) IL177388A0 (pl)
NO (1) NO20064352L (pl)
PL (1) PL1725526T3 (pl)
PT (1) PT1725526E (pl)
SI (1) SI1725526T1 (pl)
UA (1) UA86226C2 (pl)
WO (1) WO2005082848A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329418B1 (en) * 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
MXPA02009382A (es) * 2000-03-27 2003-01-28 Applied Research Systems Derivados de pirrolidina farmaceuticamente activos.
BR0211030A (pt) * 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole

Also Published As

Publication number Publication date
EP1725526A2 (en) 2006-11-29
EA200601456A1 (ru) 2007-02-27
EP1725526B1 (en) 2007-12-12
UA86226C2 (en) 2009-04-10
ATE380792T1 (de) 2007-12-15
DE602005003803D1 (de) 2008-01-24
US20070197794A1 (en) 2007-08-23
JP2007524702A (ja) 2007-08-30
WO2005082848A3 (en) 2005-12-01
CN1946686A (zh) 2007-04-11
KR20060124775A (ko) 2006-12-05
PT1725526E (pt) 2007-12-27
IL177388A0 (en) 2006-12-10
BRPI0508059A (pt) 2007-07-17
NO20064352L (no) 2006-09-26
CY1107139T1 (el) 2012-10-24
AU2005217153A1 (en) 2005-09-09
DK1725526T3 (da) 2008-03-03
DE602005003803T2 (de) 2008-12-24
WO2005082848A2 (en) 2005-09-09
CA2554767A1 (en) 2005-09-09
ES2296137T3 (es) 2008-04-16
EA011026B1 (ru) 2008-12-30
SI1725526T1 (sl) 2008-04-30

Similar Documents

Publication Publication Date Title
UA96971C2 (ru) Способ получения фторметилзамещенных гетероциклических соединений
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
TW200800997A (en) Chemical compounds
MY150538A (en) Process for the manufacture of dihydropteridinones
GB0305142D0 (en) Synthesis
NO20053991L (no) Piperazin-2-karboksamidderivater
DE502005010342D1 (en) Substituierte cyclohexylessigsäure-derivate
MX2009007231A (es) Compuestos quimicos 637:piridopirimidindionas como inhibidores de la fosfodiesterasa 4.
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
NO20055750L (no) Nye kjemiske forbindelser
PT1745010E (pt) Derivados de ciclo-hexil-1,4-diamina substituídos
TW200745106A (en) Chemical compounds
IL177388A0 (en) Method for preparing pyrrolidine oximes
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
MX2009000767A (es) Sintesis de (2s,5r)-5-etinil-1-{n-(4-metil-1-(4-carboxi-piridin-2- il)piperidin-4-il)glicil}pirrolidina-2-carbonitrilo.
IL183104A0 (en) Method for production of candesartan
NO20050980L (no) Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider
MX2008000821A (es) Nuevos derivados de piperidina.
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
TW200720225A (en) New one-step synthesis of useful disubstituted amines
RS20060049A (en) Novel n-substituted indolyl-3-glycoxylic acid amides, use thereof as a medicament and method for the production thereof